chr2-189677066-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001378068.1(ANKAR):āc.576C>Gā(p.Asp192Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000287 in 1,565,798 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001378068.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ANKAR | NM_001378068.1 | c.576C>G | p.Asp192Glu | missense_variant | 2/23 | ENST00000684021.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ANKAR | ENST00000684021.1 | c.576C>G | p.Asp192Glu | missense_variant | 2/23 | NM_001378068.1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151792Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000556 AC: 11AN: 197952Hom.: 0 AF XY: 0.0000741 AC XY: 8AN XY: 108026
GnomAD4 exome AF: 0.0000304 AC: 43AN: 1413890Hom.: 0 Cov.: 31 AF XY: 0.0000442 AC XY: 31AN XY: 701456
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151908Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74250
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 29, 2024 | The c.576C>G (p.D192E) alteration is located in exon 2 (coding exon 1) of the ANKAR gene. This alteration results from a C to G substitution at nucleotide position 576, causing the aspartic acid (D) at amino acid position 192 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at